离心分离市场 - 全球产业规模、份额、趋势、机会及预测（按产品、型号、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球离心机市场预计将从 2025 年的 87.5 亿美元成长到 2031 年的 118.1 亿美元，复合年增长率为 5.13%。

离心是一种利用离心力将溶液中的颗粒根据其不同的物理性质（例如尺寸、黏度和密度）进行分离的机械技术。该市场的成长主要受生物製药产业（尤其是疫苗生产和药物研发领域）对高效分离技术日益增长的需求所驱动。此外，血库对成分分离的迫切需求以及这些系统在临床诊断中日益广泛的应用也促进了这一增长。根据国际药品製造商协会联合会（IFPMA）2024年发布的数据，“全球有超过12,700种药品处于不同的研发阶段”，这凸显了蓬勃发展的研发环境正在推动实验室分离设备的采购。

然而，先进离心系统高昂的购买和维护成本是阻碍市场成长的一大障碍。频繁的转子校准、昂贵的零件更换以及专业的维护技术，给小规模独立实验室和医疗机构带来了沉重的经济负担，尤其是在预算有限的地区。这些费用可能会限制高速离心机和超速离心机的广泛应用。

市场驱动因素

慢性病和感染疾病率的不断上升是全球离心机市场的主要驱动力，也因此催生了对更强大的科学研究和诊断能力的需求。随着癌症和血液疾病等疾病的日益普遍，临床检查室和研究机构需要高性能离心系统来精确分离DNA、细胞物质和血液成分等生物样本，这对于准确的诊断和治疗策略至关重要。日益增长的疾病负担直接导致了对可靠实验室设备的需求增加，以满足不断增长的检测量。美国癌症协会于2024年1月发布的《2024年癌症事实与数据》预测，美国新增癌症病例数将首次超过200万例，凸显了建立健全的诊断基础设施的迫切需求。

同时，旨在发现新疗法和疫苗的医药和生技研发活动的扩张也对市场产生了重大影响。离心机在这些研发流程中发挥至关重要的作用，包括蛋白质纯化、细胞收集和活性药物成分的分离。对个人化医疗和生物製药的日益重视促使人们加大对实验室技术的投资，以确保产量和纯度。根据欧洲製药工业协会联合会（EFPIA）于2024年6月发布的《2024年製药业数据概览》，预计2023年欧洲以研发为驱动的生物製药产业研发投入将达到500亿欧元。此外，政府措施也支持这项成长。 2024年，英国政府承诺向生命科学创新製造基金拨款5.2亿英镑，以确保大规模投资并支持救命药物的生产。

市场挑战

先进离心系统高昂的购置成本和维护成本是限制全球市场成长的一大障碍。高性能设备，特别是用于基因组学和蛋白​​质组学研究的超高速离心机，需要大量的初始投资，这给中小型研究机构和独立医疗机构的预算带来了沉重负担。除了购置价格外，定期转子校准和专业技术服务以确保安全性和准确性的严格要求也增加了总拥有成本。这些持续的营运成本常常迫使采购部门推迟老旧设备的更换，从而延缓了支援市场扩张所需的更新周期。

医疗机构面临的财务压力加剧了这个问题，限制了可用于购买新设备的资金。美国医院协会 (AHA) 在 2025 年的一份报告中指出，「94% 的医疗机构管理者预计会推迟设备升级以应对财务负担。」这种财政保守主义直接影响离心机市场，降低了成本敏感地区新技术的采用率。因此，实验室往往选择延长现有设备的使用寿命，而不是投资新系统，这对整个产业的收入成长造成了显着的拖累。

市场趋势

生物製药生产中一次性离心系统的日益普及正在从根本上改变下游工作流程。在生物製药和细胞疗法需求不断增长的推动下，製造商正从传统的不銹钢设备转向一次性技术，这些技术无需清洗验证步骤，并显着降低了批次间交叉污染的风险。这种转变能够加快多产品生产设施的换线速度，提高柔软性，从而直接满足产业对操作速度和无菌性的要求。根据赛多利斯于2025年2月发布的2024年度报告，生物製程解决方案部门的订单以外汇汇率计算成长了12.7%，证实了市场对这些先进的一次性生产技术的需求正在復苏。

同时，企业净零排放承诺和不断上涨的营运成本正在加速向永续、节能的实验室设备转型。科研实验室优先选用配备碳氢化合物冷却系统、可减少摩擦的真空系统以及自动待机模式的离心机，以最大限度地减少閒置期间的电力消耗。这项转变的驱动力来自国际社会为量化和认证实验室设备的环境影响所做的努力，迫使製造商不断创新，以降低碳足迹。 2025年1月，My Green Lab在其题为《进步之年：My Green Lab 2024年主要成果》的报告中指出，国际实验室冷冻库挑战赛为参与机构节省了3180万千瓦时的能源。这一数字凸显了整个产业为提高关键设备（包括分离设备和冷冻系统）的能源效率所做的努力。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球离心机市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按产品（设备、配件）
  • 依型号类型（桌上型离心机、落地式离心机）
  • 按应用领域（临床研究、生物製药生产等）
  • 按最终用户（医院/血库、生物技术/製药实验室、学术研究机构、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美离心机市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲离心机市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区离心机市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲离心机市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲离心机市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球离心机市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Agilent Technologies, Inc.
• QIAGEN NV
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Eppendorf SE
• Corning Incorporated
• Hanil Scientific Inc.
• Daihan Scientific Co., Ltd.
• DLAB Scientific Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Centrifugation Market is projected to grow from USD 8.75 Billion in 2025 to USD 11.81 Billion by 2031, reflecting a CAGR of 5.13%. Centrifugation is a mechanical technique that employs centrifugal force to isolate particles from a solution based on distinct physical characteristics such as size, viscosity, and density. This market is primarily driven by the expanding biopharmaceutical industry, particularly the rising need for effective separation technologies in vaccine production and drug discovery. This growth is further supported by the essential requirements of blood banks for component fractionation and the increasing use of these systems in clinical diagnostics. As noted by the 'International Federation of Pharmaceutical Manufacturers and Associations' in '2024', 'there were more than 12,700 medicines in various stages of development globally', a statistic that highlights the robust research environment stimulating the procurement of laboratory separation equipment.

However, a major obstacle potentially hindering market growth is the high capital and maintenance cost linked to advanced centrifugation systems. The need for frequent rotor calibration, expensive component replacements, and specialized technical maintenance places a significant financial strain on smaller independent laboratories and healthcare facilities, especially in budget-constrained regions. These expenses can limit the widespread adoption of high-speed centrifuges and ultracentrifuges.

Market Driver

The growing incidence of chronic and infectious diseases acts as a primary catalyst for the Global Centrifugation Market, creating a need for enhanced research and diagnostic capabilities. As rates of conditions such as cancer and blood disorders rise, clinical laboratories and research institutions require high-performance centrifugation systems to precisely separate biological samples, including DNA, cellular materials, and blood components, which are vital for accurate diagnosis and treatment strategies. This increasing disease burden directly correlates with the demand for reliable laboratory equipment to manage higher testing volumes. The American Cancer Society's 'Cancer Facts & Figures 2024', released in January 2024, projects that new cancer diagnoses in the United States will exceed 2 million for the first time, underscoring the critical need for robust diagnostic infrastructure.

At the same time, the market is significantly influenced by expanding pharmaceutical and biotechnology research and development (R&D) activities aimed at discovering novel therapeutics and vaccines. Centrifuges are indispensable in these R&D workflows, utilized for protein purification, cell harvesting, and the isolation of active pharmaceutical ingredients. The intensifying focus on personalized medicine and biologics has led to increased investment in laboratory technologies that ensure yield and purity. According to the European Federation of Pharmaceutical Industries and Associations' 'The Pharmaceutical Industry in Figures 2024' from June 2024, the research-based biopharmaceutical industry is estimated to have invested €50,000 million in R&D in Europe in 2023. Furthermore, government initiatives are reinforcing this growth; the UK Government announced a £520 million commitment in 2024 for the Life Sciences Innovative Manufacturing Fund to secure major investments and support the production of life-saving medicines.

Market Challenge

The significant capital and maintenance expenses associated with advanced centrifugation systems represent a major barrier to the growth of the global market. High-performance units, particularly ultracentrifuges used in genomic and proteomic research, require a substantial upfront investment that strains the budgets of small-to-medium-sized laboratories and independent healthcare facilities. Beyond the initial purchase price, the total cost of ownership is increased by the strict requirement for regular rotor calibration and specialized technical servicing to ensure safety and precision. These ongoing operational costs often force procurement departments to postpone upgrading aging machinery, thereby slowing the replacement cycle necessary for market expansion.

Financial pressures on healthcare providers further exacerbate this issue, limiting the funds available for new capital equipment. The 'American Hospital Association' reported in '2025' that '94% of health care administrators expect to delay equipment upgrades to manage financial strain'. This fiscal conservatism directly impacts the centrifugation market by reducing the adoption rate of newer technologies in cost-sensitive regions. Consequently, laboratories frequently opt to extend the lifespan of existing units rather than investing in modern systems, creating a measurable drag on overall industry revenue growth.

Market Trends

The increasing adoption of single-use centrifugation systems in biopharmaceutical manufacturing is fundamentally altering downstream processing workflows. As the demand for biologics and cell therapies grows, manufacturers are shifting away from traditional stainless-steel equipment to disposable technologies that eliminate cleaning validation steps and significantly reduce the risk of cross-contamination between batches. This transition enables faster changeovers and greater flexibility in multi-product facilities, directly addressing the industry's need for operational speed and sterility. According to Sartorius in February 2025, within the 'Annual Report 2024', the Bioprocess Solutions Division recorded a 12.7% increase in order intake in constant currencies, underscoring the recovering market demand for these advanced single-use manufacturing technologies.

Simultaneously, there is a decisive transition towards sustainable and energy-efficient laboratory equipment, driven by corporate net-zero pledges and rising operational costs. Laboratories are increasingly prioritizing centrifuges equipped with features such as hydrocarbon-based cooling, vacuum systems to reduce friction, and automatic standby modes to minimize electricity consumption during idle periods. This shift is supported by global initiatives that quantify and certify the environmental impact of research hardware, pushing manufacturers to innovate for lower carbon footprints. My Green Lab reported in 'A Year of Progress: My Green Lab's Key Achievements in 2024' in January 2025 that the International Laboratory Freezer Challenge resulted in participants saving 31.8 million kWh of energy, a metric that highlights the sector's broader commitment to reducing the energy intensity of essential devices including separation and cold-storage systems.

Key Market Players

• Agilent Technologies, Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Eppendorf SE
• Corning Incorporated
• Hanil Scientific Inc.
• Daihan Scientific Co., Ltd.
• DLAB Scientific Co., Ltd.

Report Scope

In this report, the Global Centrifugation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Centrifugation Market, By Product

• Equipment
• Accessories

Centrifugation Market, By Model Type

• Benchtop Centrifuges
• Floor-Standing Centrifuges

Centrifugation Market, By Application

• Clinical Research
• Biotherapeutic Manufacturing
• Others

Centrifugation Market, By End-User

• Hospitals and Blood Banks
• Biotechnology and Pharmaceutical Laboratories
• Academic and Research Institutes
• Others

Centrifugation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Centrifugation Market.

Available Customizations:

Global Centrifugation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Centrifugation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Equipment, Accessories)
  • 5.2.2. By Model Type (Benchtop Centrifuges, Floor-Standing Centrifuges)
  • 5.2.3. By Application (Clinical Research, Biotherapeutic Manufacturing, Others)
  • 5.2.4. By End-User (Hospitals and Blood Banks, Biotechnology and Pharmaceutical Laboratories, Academic and Research Institutes, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Centrifugation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Model Type
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Centrifugation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Model Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Centrifugation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Model Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Centrifugation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Model Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User

7. Europe Centrifugation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Model Type
  • 7.2.3. By Application
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Centrifugation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Model Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Centrifugation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Model Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Centrifugation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Model Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Centrifugation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Model Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Centrifugation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Model Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia Pacific Centrifugation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Model Type
  • 8.2.3. By Application
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Centrifugation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Model Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Centrifugation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Model Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Centrifugation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Model Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Centrifugation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Model Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Centrifugation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Model Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Centrifugation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Model Type
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Centrifugation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Model Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Centrifugation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Model Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Centrifugation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Model Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User

10. South America Centrifugation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Model Type
  • 10.2.3. By Application
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Centrifugation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Model Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Centrifugation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Model Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Centrifugation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Model Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Centrifugation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Agilent Technologies, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. QIAGEN N.V.
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Thermo Fisher Scientific, Inc.
• 15.5. Danaher Corporation
• 15.6. Eppendorf SE
• 15.7. Corning Incorporated
• 15.8. Hanil Scientific Inc.
• 15.9. Daihan Scientific Co., Ltd.
• 15.10. DLAB Scientific Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer